US 11052057
Use of cysteamine and derivatives thereof to suppress tumor metastases
granted A61KA61K31/145A61K45/06
Quick answer
US patent 11052057 (Use of cysteamine and derivatives thereof to suppress tumor metastases) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/145, A61K45/06, A61K9/0053, A61K9/28